Free Trial

Orchestra BioMed (OBIO) Competitors

Orchestra BioMed logo
$3.32 -0.36 (-9.78%)
Closing price 04:00 PM Eastern
Extended Trading
$3.32 0.00 (0.00%)
As of 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OBIO vs. TMCI, DCTH, CARL, NPCE, DRTS, RXST, TCMD, BWAY, SMTI, and SNWV

Should you be buying Orchestra BioMed stock or one of its competitors? The main competitors of Orchestra BioMed include Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Carlsmed (CARL), NeuroPace (NPCE), Alpha Tau Medical (DRTS), RxSight (RXST), Tactile Systems Technology (TCMD), Brainsway (BWAY), Sanara MedTech (SMTI), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry.

Orchestra BioMed vs. Its Competitors

Orchestra BioMed (NASDAQ:OBIO) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

53.2% of Orchestra BioMed shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 8.1% of Orchestra BioMed shares are held by insiders. Comparatively, 27.7% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Orchestra BioMed has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500.

Orchestra BioMed currently has a consensus price target of $13.50, suggesting a potential upside of 306.63%. Treace Medical Concepts has a consensus price target of $9.67, suggesting a potential upside of 50.10%. Given Orchestra BioMed's stronger consensus rating and higher possible upside, equities analysts clearly believe Orchestra BioMed is more favorable than Treace Medical Concepts.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orchestra BioMed
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
Treace Medical Concepts
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14

In the previous week, Treace Medical Concepts had 1 more articles in the media than Orchestra BioMed. MarketBeat recorded 3 mentions for Treace Medical Concepts and 2 mentions for Orchestra BioMed. Treace Medical Concepts' average media sentiment score of 0.77 beat Orchestra BioMed's score of 0.67 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orchestra BioMed
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Treace Medical Concepts
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Treace Medical Concepts has higher revenue and earnings than Orchestra BioMed. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Orchestra BioMed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orchestra BioMed$2.64M48.59-$61.02M-$1.83-1.81
Treace Medical Concepts$209.36M1.94-$55.74M-$0.79-8.15

Treace Medical Concepts has a net margin of -23.01% compared to Orchestra BioMed's net margin of -2,367.49%. Treace Medical Concepts' return on equity of -46.76% beat Orchestra BioMed's return on equity.

Company Net Margins Return on Equity Return on Assets
Orchestra BioMed-2,367.49% -289.42% -110.04%
Treace Medical Concepts -23.01%-46.76%-23.35%

Summary

Treace Medical Concepts beats Orchestra BioMed on 11 of the 17 factors compared between the two stocks.

Get Orchestra BioMed News Delivered to You Automatically

Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OBIO vs. The Competition

MetricOrchestra BioMedMED IndustryMedical SectorNASDAQ Exchange
Market Cap$142.21M$3.40B$6.11B$10.51B
Dividend YieldN/A2.29%5.73%4.81%
P/E Ratio-1.818.1063.4522.93
Price / Sales48.59484.29609.45131.82
Price / CashN/A46.5937.1661.22
Price / Book3.8210.4112.246.52
Net Income-$61.02M-$52.47M$3.32B$276.75M
7 Day Performance5.40%2.30%0.76%0.92%
1 Month Performance34.96%14.45%8.03%4.20%
1 Year Performance-38.75%12.90%71.13%37.86%

Orchestra BioMed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OBIO
Orchestra BioMed
2.7845 of 5 stars
$3.32
-9.8%
$13.50
+306.6%
-35.0%$142.21M$2.64M-1.814News Coverage
TMCI
Treace Medical Concepts
2.1752 of 5 stars
$6.06
-3.9%
$9.83
+62.4%
+18.8%$382.49M$209.36M-7.66250Analyst Forecast
DCTH
Delcath Systems
2.1436 of 5 stars
$10.76
-0.4%
$24.50
+127.7%
+30.0%$376.40M$70.24M215.2060
CARL
Carlsmed
N/A$13.67
-5.6%
N/AN/A$363.35M$27.17M0.00100News Coverage
Analyst Forecast
Short Interest ↑
NPCE
NeuroPace
2.8636 of 5 stars
$10.61
-1.5%
$16.60
+56.5%
+65.2%$350.81M$79.91M-12.63170Positive News
DRTS
Alpha Tau Medical
2.8161 of 5 stars
$4.14
-2.0%
$9.00
+117.7%
+70.6%$349.46MN/A-8.5880News Coverage
RXST
RxSight
2.3234 of 5 stars
$8.31
-2.2%
$10.00
+20.4%
-83.3%$341.89M$139.93M-10.44220
TCMD
Tactile Systems Technology
3.8418 of 5 stars
$14.90
-1.8%
$16.83
+13.0%
+2.2%$331.71M$298.85M24.001,037
BWAY
Brainsway
3.4752 of 5 stars
$15.32
+0.6%
$18.00
+17.5%
+66.7%$290.67M$46.08M58.93120Analyst Forecast
SMTI
Sanara MedTech
2.4568 of 5 stars
$30.38
-2.8%
$50.00
+64.6%
-6.4%$272.58M$97.24M-26.4060
SNWV
Sanuwave Health
3.2151 of 5 stars
$31.79
-22.1%
$54.00
+69.9%
N/A$272.44M$32.63M-3.8540Short Interest ↑
High Trading Volume

Related Companies and Tools


This page (NASDAQ:OBIO) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners